(Q34523880)

2 August 2017

1 reference

title

Therapy with macrolides in patients with cystic fibrosis (English)

1 reference

2 August 2017

0 references

Allyson S Gaylor

1

1 reference

PubMed ID

11837560

2 August 2017

Joan C Reilly

series ordinal

2

1 reference

PubMed ID

11837560

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

2 August 2017

1 reference

2 August 2017

22

1 reference

2 August 2017

2

1 reference

2 August 2017

227-239

1 reference

Erythromycin and diffuse panbronchiolitis

2 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Induction of beta-lactamase and methicillin resistance in unusual strains of methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Macrolide drug interactions: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Comparison of the clinical and bacteriological efficacy of clarithromycin and erythromycin in the treatment of streptococcal pharyngitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Ototoxicity with azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Pharmacokinetics and pharmacodynamics of newer macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Nonantibiotic effects of macrolide antibiotics of the oleandomycin-erythromycin group with special reference to their "steroid-sparing" effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Inhibition of theophylline clearance by troleandomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Diffuse panbronchiolitis and cystic fibrosis: East meets West

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Buccal adherence of Pseudomonas aeruginosa in patients with cystic fibrosis under long-term therapy with azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Inflammatory cytokines in cystic fibrosis lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Azithromycin, the multidrug-resistant protein, and cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

Macrolide antibiotics in diffuse panbronchiolitis and in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.3.227.33544

10.1592/PHCO.22.3.227.33544

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11837560